Inari Medical Future Growth
Future criteria checks 4/6
Inari Medical is forecast to grow earnings and revenue by 74% and 14.8% per annum respectively. EPS is expected to grow by 74.4% per annum. Return on equity is forecast to be 8.8% in 3 years.
Key information
74.0%
Earnings growth rate
74.4%
EPS growth rate
| Medical Equipment earnings growth | 15.9% |
| Revenue growth rate | 14.8% |
| Future return on equity | 8.8% |
| Analyst coverage | Good |
| Last updated | 17 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 823 | 19 | 24 | 55 | 11 |
| 12/31/2025 | 707 | -4 | -11 | 27 | 15 |
| 12/31/2024 | 600 | -66 | -30 | -4 | 15 |
| 6/30/2024 | 547 | -57 | 17 | 27 | N/A |
| 3/31/2024 | 521 | -24 | 19 | 26 | N/A |
| 12/31/2023 | 494 | -2 | 30 | 36 | N/A |
| 9/30/2023 | 469 | -3 | 29 | 35 | N/A |
| 6/30/2023 | 439 | -16 | 0 | 6 | N/A |
| 3/31/2023 | 413 | -28 | -15 | -7 | N/A |
| 12/31/2022 | 383 | -29 | -24 | -14 | N/A |
| 9/30/2022 | 359 | -22 | -21 | -10 | N/A |
| 6/30/2022 | 336 | -15 | -16 | -3 | N/A |
| 3/31/2022 | 306 | -1 | -8 | 8 | N/A |
| 12/31/2021 | 277 | 10 | 12 | 25 | N/A |
| 9/30/2021 | 242 | 16 | -4 | 9 | N/A |
| 6/30/2021 | 208 | 25 | 10 | 20 | N/A |
| 3/31/2021 | 170 | 17 | 5 | 11 | N/A |
| 12/31/2020 | 140 | 14 | -4 | 2 | N/A |
| 9/30/2020 | 111 | 7 | -1 | 3 | N/A |
| 6/30/2020 | 86 | 1 | -7 | -3 | N/A |
| 3/31/2020 | 71 | 4 | -7 | -4 | N/A |
| 12/31/2019 | 51 | -1 | -8 | -5 | N/A |
| 12/31/2018 | 7 | -10 | -12 | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IM7 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: IM7 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: IM7 is expected to become profitable in the next 3 years.
Revenue vs Market: IM7's revenue (14.8% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: IM7's revenue (14.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IM7's Return on Equity is forecast to be low in 3 years time (8.8%).